EASY BIO,INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,100 KRW | +0.24% |
|
-1.32% | +13.26% |
| 02-16 | Easy Bio USA, Inc. announced that it expects to receive KRW 47.3286 billion in funding from EASY BIO,Inc. | CI |
| 2022 | EASY BIO,Inc.(KOSDAQ:A353810) dropped from S&P Global BMI Index | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 161,639 | 137,402 | 123,576 |
| Enterprise Value (EV) 1 | 190,962 | 178,252 | 175,142 |
| P/E ratio | 14.9 x | 15 x | 7.96 x |
| Yield | 1.58% | 1.86% | 2.76% |
| Capitalization / Revenue | 1.25 x | 0.88 x | 0.75 x |
| EV / Revenue | 1.48 x | 1.15 x | 1.06 x |
| EV / EBITDA | 9.75 x | 8.95 x | 7.2 x |
| EV / FCF | - | -19,589,165 x | -17,107,274 x |
| FCF Yield | - | -0% | -0% |
| Price to Book | 3.77 x | 2.75 x | 1.97 x |
| Nbr of stocks (in thousands) | 34,137 | 34,137 | 34,137 |
| Reference price 2 | 4,735 | 4,025 | 3,620 |
| Announcement Date | 22-03-23 | 23-03-23 | 24-03-21 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 129,458 | 155,557 | 165,385 |
| EBITDA 1 | 19,580 | 19,918 | 24,323 |
| EBIT 1 | 16,779 | 16,155 | 20,631 |
| Operating Margin | 12.96% | 10.39% | 12.47% |
| Earnings before Tax (EBT) 1 | 14,054 | 11,984 | 20,066 |
| Net income 1 | 10,873 | 9,131 | 15,544 |
| Net margin | 8.4% | 5.87% | 9.4% |
| EPS 2 | 318.5 | 267.5 | 455.0 |
| Free Cash Flow | - | -9,100 | -10,238 |
| FCF margin | - | -5.85% | -6.19% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share 2 | 75.00 | 75.00 | 100.0 |
| Announcement Date | 22-03-23 | 23-03-23 | 24-03-21 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | 29,322 | 40,850 | 51,566 |
| Net Cash position 1 | - | - | - |
| Leverage (Debt/EBITDA) | 1.498 x | 2.051 x | 2.12 x |
| Free Cash Flow | - | -9,100 | -10,238 |
| ROE (net income / shareholders' equity) | - | 19% | 27.1% |
| ROA (Net income/ Total Assets) | - | 7.33% | 7.82% |
| Assets 1 | - | 124,570 | 198,813 |
| Book Value Per Share 2 | 1,257 | 1,464 | 1,839 |
| Cash Flow per Share 2 | 606.0 | 1,169 | 852.0 |
| Capex 1 | 1,834 | 1,954 | 1,886 |
| Capex / Sales | 1.42% | 1.26% | 1.14% |
| Announcement Date | 22-03-23 | 23-03-23 | 24-03-21 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +13.26% | 103M | |
| +12.83% | 11.62B | |
| -2.04% | 5.71B | |
| +5.47% | 5.41B | |
| +3.06% | 4.51B | |
| -20.13% | 2.71B | |
| +3.25% | 1.92B | |
| -19.47% | 1.19B | |
| -17.18% | 960M | |
| -13.20% | 924M |
- Stock Market
- Equities
- A353810 Stock
- Financials EASY BIO,Inc.